Search Results 51-60 of 17001 for monoclonal antibody

1. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

   A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors · Share · Facebook ...

2. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

   Monoclonal antibodies, such as varlilumab and nivolumab, may work by ... History of severe hypersensitivity reaction to any monoclonal antibody.

3. Hematology - Clinical trials

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

4. Antibody Treatment for Advanced Celiac Disease - Mayo Clinic

   Patients with antibodies to Hu-Mik-Beta-1; A contraindication to monoclonal antibody therapy including adverse events related to prior monoclonal antibody ...

5. A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

   Clinical Trials · A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors · More about research at Mayo Clinic · Mayo ...

6. Clinical trials - Oncology (Medical)

   Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

7. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

   Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... At least 6 weeks since prior monoclonal antibody therapy; At least 7 ...

8. A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas - Mayo Clinic

   A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory ...

9. Chemotherapy Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Giving imiquimod and pembrolizumab may work ...

10. Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may block tumor growth in different ... History of severe hypersensitivity reaction to any monoclonal antibody ...